alexa
Reach Us +1-947-333-4405
Strategic Analysis Of The European Vaccines Market For Infectious Diseases - Understanding The Quantitative Aspects And Leveraging Growth Opportunities For Vaccines Manufacturers | 9890
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Vaccines & Vaccination

Aiswariya Chidambaram
Accepted Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.018
Abstract
T his research service aims to assess and analyze the European vaccines market, particularly the key five countries of Western Europe namely Germany, the United Kingdom, France, Italy and Spain, map the key trends and dynamics shaping the industry sector, and provide economic revenue forecasts and strategic recommendations for the success of the market participants. The European vaccines market, valued at $6.36 billion in 2011 is expected to grow at a compound annual growth rate of 9.6 per cent over the next seven years. Market segmentation is done based on demographics which include adult and paediatric vaccines as well the key infectious diseases which include Measles-Mumps-Rubella (MMR), Diphtheria-Tetanus-Pertussis (DTP), influenza, hepatitis, Human Papilloma Virus (HPV) cancer, rotavirus infection, meningococcal and pneumococcal diseases. Although Europe has been enjoying the leadership position in the global vaccines market over a decade in terms of vaccines research, development, and production, a rapid shift in power to the United States and the narrowing of the gap between the two regions is anticipated in the future, owing to the rapid growth, increasing R&D investments and relative competitiveness of the United States. As vaccine manufacturers increasingly leverage the novel technologies, and potential late-stage vaccine candidates progress the pipeline and reach the commercialisation stage, several new vaccines for both infectious diseases such as AIDS, dengue fever, tuberculosis, and malaria as well as non-infectious diseases like diabetes, allergies, Alzheimer?s disease, cancers, addictions, and public health threats (bio-terrorism) are likely to be available in the future. Next-generation vaccines such as edible plant-based vaccines are also likely to have a significant impact on vaccine development. Research methodology involves extensive secondary research from sources such as Frost & Sullivan?s in-house database, company annual reports, scientific journals, private and public organisations such as WHO, EBC, Alzheimer Europe and so on as well primary interviews with industry stake holders such as tier 1 and tier 2 companies, industry associations, healthcare providers and regulatory authorities.
Biography
Aiswariya Chidambaram is a senior research analyst within the healthcare practice of Frost & Sullivan. She has authored several syndicated and customised market research reports on key therapeutic and service areas for both the European and Global pharmaceutical and biotechnology markets. Besides she has contributed articles, briefings and interviews to widely read publications worldwide such as PharmaVoice, European Public Service Review, European Biopharmaceutical Review, to name a few and has also identified and awarded companies demonstrating excellence in specific market segments and technologies in the healthcare industry . Aiswariya has completed her B.Tech in Biotechnology from Anna University.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version